Age, Biography and Wiki
Audrey Evans was born on 6 March, 1925, is an English paediatric oncologist (1925–2022). Discover Audrey Evans's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is she in this year and how she spends money? Also learn how she earned most of networth at the age of 97 years old?
Popular As |
N/A |
Occupation |
N/A |
Age |
97 years old |
Zodiac Sign |
Pisces |
Born |
6 March 1925 |
Birthday |
6 March |
Birthplace |
N/A |
Date of death |
29 September, 2022 |
Died Place |
N/A |
Nationality |
|
We recommend you to check the complete list of Famous People born on 6 March.
She is a member of famous with the age 97 years old group.
Audrey Evans Height, Weight & Measurements
At 97 years old, Audrey Evans height not available right now. We will update Audrey Evans's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.
Physical Status |
Height |
Not Available |
Weight |
Not Available |
Body Measurements |
Not Available |
Eye Color |
Not Available |
Hair Color |
Not Available |
Dating & Relationship status
She is currently single. She is not dating anyone. We don't have much information about She's past relationship and any previous engaged. According to our Database, She has no children.
Family |
Parents |
Not Available |
Husband |
Not Available |
Sibling |
Not Available |
Children |
Not Available |
Audrey Evans Net Worth
Her net worth has been growing significantly in 2023-2024. So, how much is Audrey Evans worth at the age of 97 years old? Audrey Evans’s income source is mostly from being a successful . She is from . We have estimated Audrey Evans's net worth, money, salary, income, and assets.
Net Worth in 2024 |
$1 Million - $5 Million |
Salary in 2024 |
Under Review |
Net Worth in 2023 |
Pending |
Salary in 2023 |
Under Review |
House |
Not Available |
Cars |
Not Available |
Source of Income |
|
Audrey Evans Social Network
Instagram |
|
Linkedin |
|
Twitter |
|
Facebook |
|
Wikipedia |
|
Imdb |
|
Timeline
Audrey Elizabeth Evans (6 March 1925 – 29 September 2022) was a British-born American pediatric oncologist who was known as the "Mother of Neuroblastoma".
Evans was one of the co-founders of the original Ronald McDonald House in Philadelphia as well as a co-founder of Philadelphia's St. James School.
She spent most of her career working at the Children's Hospital of Philadelphia.
She was the youngest of three children born into a middle-class family.
Her sister was six years older than her and her brother two years older.
She attended a Quaker school before heading to a boarding school in Bristol, England where she stayed until the start of World War II.
After the war began she went home and attended The Mount School in York, England.
During her senior year, she developed tuberculosis causing her to miss school.
Evans trained at the Royal College of Surgeons of Edinburgh in the early 1950s.
She was the only female student in the medical school.
She struggled during her first year of medical school and ended up failing.
She attributes her failing to the fact that she learned by listening and not by reading.
She did two years of residency at the Royal Infirmary of Edinburgh where she was the only female in the program.
After finishing her degree in 1953, she applied and received the Fulbright Fellowship at Boston Children's Hospital.
She trained there for two years under Sidney Farber, who is known as the father of modern chemotherapy.
She went to Johns Hopkins University to finish her medical training in 1955.
In 1955, after she had finished medical training in the United States, she returned to England to practice specialty pediatrics.
She soon learned that this field was strictly for men and not women.
So, she headed back to the United States to pick up her career in pediatric oncology.
She worked at Boston Children's Hospital at first.
In 1964, she headed to the University of Chicago, to work at their hematology and oncology unit.
Here, Evans was recruited by C. Everett Coop, former U.S Surgeon General and Surgeon Chief at the Children's Hospital of Philadelphia (CHOP), to create a pediatric oncology unit.
She spent the rest of her career at CHOP.
Throughout her career she took a total care approach towards her patients, meaning that she did not just focus on her patients' physical needs but also their social, emotional, spiritual needs as well as supporting the families.
From 1969 to 1989, she served as chair of the Division of Oncology at the Children's Hospital of Philadelphia and in 1972 was appointed a professor of pediatrics at the University of Pennsylvania School of Medicine.
Evans was known as the "Mother of Neuroblastoma" because of all of her work for neuroblastoma.
After years of treating children with neuroblastoma she reduced its mortality rate by about fifty percent.
Currently, the survival rate is above eighty five percent.
In the early 1970s Evans was introduced to The Philadelphia Eagles owner, when the team had raised $100,000 for children with cancer in honor of one of the player's daughters who had leukemia.
Evans accepted the money from Eagles owner, Jimmy Murray, and let him know that she needed $32,000 more in order to buy a house for the children and their families.
In 1971, she created the Evans staging system for Neuroblastoma.
In 1971, she created the Evans staging system to determine neuroblastoma disease progression and to determine what treatments would be most effective.
Evans described a staging system from one to four.
Evans and D'Angio were the first to describe the phenomenon of spontaneous regression of widely spread neuroblastoma that they later dubbed "4S disease".
This spontaneous regression usually occurs in infants younger than 6 months old.
As CHOP's pediatric oncology department grew, people were coming from a wide range of places to be treated there.
Evans realized that the families of the children that were being treated had no place to stay and would often get separated to different locations.
Evans also instituted and chaired the early meetings for Advances in Neuroblastoma Research on 30 May 1975, as a series of symposia held at Children's Hospital of Philadelphia.
The conference is designed to promote the exchange of information among investigators studying Neuroblastoma biology, diagnosis, prognosis, and therapy.